{"id":"https://openalex.org/W7225098417","doi":"https://doi.org/10.1016/j.rcsop.2026.100873","title":"Enhancing adverse drug reaction reporting through a pharmacy-led multi-component intervention: A real-world pre\u2013post evaluation","display_name":"Enhancing adverse drug reaction reporting through a pharmacy-led multi-component intervention: A real-world pre\u2013post evaluation","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225098417","doi":"https://doi.org/10.1016/j.rcsop.2026.100873"},"language":"en","primary_location":{"id":"doi:10.1016/j.rcsop.2026.100873","doi":"https://doi.org/10.1016/j.rcsop.2026.100873","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rcsop.2026.100873","pdf_url":"https://www.sciencedirect.com/science/article/pii/S266727662600171X/pdf","source":{"id":"https://openalex.org/S4210220726","display_name":"Exploratory Research in Clinical and Social Pharmacy","issn_l":"2667-2766","issn":["2667-2766"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Exploratory Research in Clinical and Social Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S266727662600171X/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5122127415","display_name":"Musaad Alruwaili","orcid":"https://orcid.org/0009-0008-7774-7475","observed_orcids":["https://orcid.org/0009-0008-7774-7475"]},"institutions":[{"id":"https://openalex.org/I145380033","display_name":"Amman Arab University","ror":"https://ror.org/039xekb14","country_code":"JO","type":"education","lineage":["https://openalex.org/I145380033"]},{"id":"https://openalex.org/I4210127754","display_name":"Ministry of Health","ror":"https://ror.org/030atj633","country_code":"SA","type":"government","lineage":["https://openalex.org/I4210127754"]}],"countries":["JO","SA"],"is_corresponding":false,"raw_author_name":"Musaad Alruwaili","raw_affiliation_strings":["College of Pharmacy, Amman Arab University, Amman, Jordan","Pharmacy Department, Turaif General Hospital, Northern Health Cluster, Ministry of Health, Turaif, Saudi Arabia"],"raw_orcid":"https://orcid.org/0009-0008-7774-7475","affiliations":[{"raw_affiliation_string":"College of Pharmacy, Amman Arab University, Amman, Jordan","institution_ids":["https://openalex.org/I145380033"]},{"raw_affiliation_string":"Pharmacy Department, Turaif General Hospital, Northern Health Cluster, Ministry of Health, Turaif, Saudi Arabia","institution_ids":["https://openalex.org/I4210127754"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035024382","display_name":"Rana Abu\u2010Huwaij","orcid":"https://orcid.org/0000-0002-0798-7069","observed_orcids":["https://orcid.org/0000-0002-0798-7069"]},"institutions":[{"id":"https://openalex.org/I145380033","display_name":"Amman Arab University","ror":"https://ror.org/039xekb14","country_code":"JO","type":"education","lineage":["https://openalex.org/I145380033"]}],"countries":["JO"],"is_corresponding":true,"raw_author_name":"Rana Abu-Huwaij","raw_affiliation_strings":["College of Pharmacy, Amman Arab University, Amman, Jordan"],"raw_orcid":"https://orcid.org/0000-0002-0798-7069","affiliations":[{"raw_affiliation_string":"College of Pharmacy, Amman Arab University, Amman, Jordan","institution_ids":["https://openalex.org/I145380033"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070759755","display_name":"Mohammad A. Khaleel","orcid":"https://orcid.org/0000-0001-5845-2729","observed_orcids":["https://orcid.org/0000-0001-5845-2729"]},"institutions":[{"id":"https://openalex.org/I145380033","display_name":"Amman Arab University","ror":"https://ror.org/039xekb14","country_code":"JO","type":"education","lineage":["https://openalex.org/I145380033"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Mohammad A. Khaleel","raw_affiliation_strings":["College of Pharmacy, Amman Arab University, Amman, Jordan"],"raw_orcid":"https://orcid.org/0000-0001-5845-2729","affiliations":[{"raw_affiliation_string":"College of Pharmacy, Amman Arab University, Amman, Jordan","institution_ids":["https://openalex.org/I145380033"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5035024382"],"corresponding_institution_ids":["https://openalex.org/I145380033"],"apc_list":{"value":2140,"currency":"USD","value_usd":2140},"apc_paid":{"value":2140,"currency":"USD","value_usd":2140},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8409399,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":null,"first_page":"100873","last_page":"100873"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/3604","display_name":"Emergency Medical Services"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8659999966621399},{"id":"https://openalex.org/keywords/adverse-drug-reaction-reporting","display_name":"adverse drug reaction reporting","score":0.859000027179718},{"id":"https://openalex.org/keywords/multicomponent-intervention","display_name":"multicomponent intervention","score":0.8100000023841858},{"id":"https://openalex.org/keywords/patient-safety","display_name":"patient safety","score":0.5889999866485596},{"id":"https://openalex.org/keywords/pre-post-assessment","display_name":"pre- and post-assessment","score":0.5899999737739563},{"id":"https://openalex.org/keywords/role-of-pharmacists","display_name":"pharmacist role","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6650999784469604},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4869999885559082},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.43619999289512634},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.38589999079704285},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.34940001368522644},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.34290000796318054},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3018999993801117},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.28029999136924744},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.27880001068115234},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.27790001034736633},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25619998574256897},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.25130000710487366}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.rcsop.2026.100873","doi":"https://doi.org/10.1016/j.rcsop.2026.100873","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rcsop.2026.100873","pdf_url":"https://www.sciencedirect.com/science/article/pii/S266727662600171X/pdf","source":{"id":"https://openalex.org/S4210220726","display_name":"Exploratory Research in Clinical and Social Pharmacy","issn_l":"2667-2766","issn":["2667-2766"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Exploratory Research in Clinical and Social Pharmacy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.rcsop.2026.100873","doi":"https://doi.org/10.1016/j.rcsop.2026.100873","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rcsop.2026.100873","pdf_url":"https://www.sciencedirect.com/science/article/pii/S266727662600171X/pdf","source":{"id":"https://openalex.org/S4210220726","display_name":"Exploratory Research in Clinical and Social Pharmacy","issn_l":"2667-2766","issn":["2667-2766"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Exploratory Research in Clinical and Social Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225098417.pdf","grobid_xml":"https://content.openalex.org/works/W7225098417.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1992167600","https://openalex.org/W2009890917","https://openalex.org/W2082494913","https://openalex.org/W2119694597","https://openalex.org/W2169559966","https://openalex.org/W2801007166","https://openalex.org/W2890243962","https://openalex.org/W3162595304","https://openalex.org/W4365451694","https://openalex.org/W4366982067","https://openalex.org/W4378639823","https://openalex.org/W4379509131","https://openalex.org/W4392353959","https://openalex.org/W4405576830","https://openalex.org/W4410288963","https://openalex.org/W4415620142","https://openalex.org/W7117478036"],"related_works":["https://openalex.org/W3146211944","https://openalex.org/W2600497500","https://openalex.org/W7063706334","https://openalex.org/W2408868553","https://openalex.org/W163718979","https://openalex.org/W2972630806","https://openalex.org/W1564179300","https://openalex.org/W1596477382","https://openalex.org/W4411469118","https://openalex.org/W3172615485"],"abstract_inverted_index":{"Background":[0],"Underreporting":[1],"of":[2,52,107,193],"adverse":[3],"drug":[4],"reactions":[5],"(ADRs)":[6],"remains":[7,42],"a":[8,53,63,108,127,136,184],"major":[9],"challenge":[10],"in":[11,17,113],"pharmacovigilance":[12,224],"despite":[13],"established":[14],"reporting":[15,34,68,97,111,214],"systems":[16],"Saudi":[18,81],"Arabia.":[19,82],"Limited":[20],"healthcare":[21],"professional":[22,216],"(HCP)":[23],"engagement,":[24,61],"inadequate":[25],"awareness,":[26],"and":[27,49,62,90,101,120,150,167,188,203,209,218,225],"low":[28,33],"patient":[29],"participation":[30],"contribute":[31],"to":[32,94,180],"rates,":[35],"while":[36],"evidence":[37],"on":[38],"integrated":[39],"real-world":[40,50],"interventions":[41],"scarce.":[43],"Objective":[44],"To":[45],"evaluate":[46],"the":[47,92,114,162,189],"feasibility":[48],"impact":[51],"pragmatic,":[54,198],"multi-component":[55],"intervention":[56,93,104,200],"combining":[57],"HCP":[58,118,141,206],"education,":[59,119],"community":[60,121,219],"QR":[64,109],"code\u2013based":[65,110],"digital":[66,213],"ADR":[67,96,124,173,210],"system.":[69],"Methods":[70],"A":[71],"quasi-experimental":[72],"pre\u2013post":[73],"study":[74],"was":[75,201],"conducted":[76],"at":[77,178],"Turaif":[78],"General":[79],"Hospital,":[80],"Seventy-eight":[83],"matched":[84],"HCPs":[85],"completed":[86],"validated":[87],"questionnaires":[88],"before":[89],"after":[91,161],"assess":[95],"knowledge,":[98,207],"perceptions,":[99,208],"barriers,":[100],"facilitators.":[102],"The":[103],"included":[105],"implementation":[106],"system":[112],"outpatient":[115],"pharmacy,":[116],"targeted":[117],"awareness":[122],"activities.":[123],"reports":[125,174],"during":[126],"4-month":[128,137],"baseline":[129,179],"period":[130],"were":[131],"compared":[132],"with":[133,215],"those":[134],"from":[135,176],"post-intervention":[138],"period.":[139],"Results":[140],"knowledge":[142],"(mean":[143,152],"difference":[144,153],"=":[145,148,154,157],"0.311;":[146],"p":[147,156],"0.0092)":[149],"perceptions":[151],"0.354;":[155],"0.0037)":[158],"improved":[159,205],"significantly":[160],"intervention,":[163],"whereas":[164],"perceived":[165],"barriers":[166],"facilitators":[168],"did":[169],"not":[170],"change":[171],"significantly.":[172],"increased":[175],"11":[177],"156":[181],"post-intervention,":[182],"representing":[183],"14.2-fold":[185],"increase.":[186],"Patients":[187],"public":[190],"submitted":[191],"33%":[192],"all":[194],"reports.":[195],"Conclusion":[196],"This":[197],"pharmacy-led":[199],"feasible":[202],"substantially":[204],"reporting.":[211],"Integrating":[212],"education":[217],"engagement":[220],"may":[221],"strengthen":[222],"patient-centered":[223],"medication":[226],"safety.":[227]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-03T00:00:00"}